PATENT CLAIM ANALYSIS

Application Number: 16449547
Application Type: Utility
Filing Date: 2019-06
Publication Date: 2019-10
Patent Classification: ["424", "185100"]

Abstract:
The subject invention pertains to peptides and salts thereof that are useful as anti-inflammatory agents and to compositions containing such peptides and salts as active ingredients. Specifically exemplified herein are endomorphin-1 peptide (EM-1), analogs and salts thereof, and uses for modulation of calcitonin gene-related peptide (CGRP) production and/or substance P (SP) and for treatment of inflammation, particularly neurogenic inflammation.

Claim (Index 5):
The composition, according to  claim 1 , further comprising acetate ions.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 100.0
- Lexical Diversity: 1.48936
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['16035274', '15511697', '13908636', '14830572', '12064923']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6944774049219855
- 35 USC 102 Novelty (BERT): 0.5587936346221575
- Combined Prediction Score: 0.6809090278920028
- Mean Citation Score: 280.679628
- Max Citation Score: 487.30615
- Similarity Product: 302.13440454583167

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test